| Teva Pharma AG - DuoResp Spiromax 320 ug / 9 ug, Pulver zur Inhalation |
| 70193 | | 02 | | DuoResp Spiromax 320 ug / 9 ug | | Pulver zur Inhalation | | R03AK07 | | Formoterol and Budesonide | | 02.04.2026 | | |
|
| Composition |
| budesonidum 320 µg, formoteroli fumaras dihydricus 9 µg, lactosum monohydricum 10 mg, ad pulverem pro dosi. |
| Packungsbestandteile |
| Inhalation Powder | | | | | | | | Active Agent | Dose |
|---|
| Budesonide | 320 µg | | Formoteroli Fumaras Dihydricus | 9 µg |
| | BAG: Active Agent |
|---|
| Budesonide | | Formoteroli Fumaras Dihydricus |
| | | | Inactive agents | Dose |
|---|
| Lactose Monohydrate | 10 mg |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 60 | 36.99 | 56.65 | B | SL | No | | 004 | 3 x 60 | | | B | | Yes |
|
